113.94
2.32%
2.5982
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$111.34
Aprire:
$111.38
Volume 24 ore:
286.59K
Relative Volume:
0.39
Capitalizzazione di mercato:
$13.55B
Reddito:
$2.72B
Utile/perdita netta:
$254.30M
Rapporto P/E:
19.16
EPS:
5.9463
Flusso di cassa netto:
$564.37M
1 W Prestazione:
-1.83%
1M Prestazione:
-4.46%
6M Prestazione:
+0.62%
1 anno Prestazione:
+28.12%
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-6900
Indirizzo
77 4TH AVENUE, WALTHAM
Confronta RVTY con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
RVTY | 113.92 | 13.55B | 2.72B | 254.30M | 564.37M | 5.9463 |
TMO | 509.17 | 195.55B | 42.37B | 6.14B | 7.78B | 15.26 |
DHR | 231.40 | 166.92B | 23.74B | 3.89B | 4.98B | 7.93 |
A | 131.16 | 36.94B | 6.50B | 1.41B | 1.42B | 3.82 |
IQV | 194.95 | 35.03B | 15.32B | 1.41B | 1.96B | 5.95 |
IDXX | 411.72 | 33.80B | 3.84B | 866.24M | 792.60M | 9.80 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-01-16 | Downgrade | UBS | Buy → Neutral |
2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
2023-09-28 | Iniziato | Bernstein | Outperform |
2023-07-19 | Iniziato | Raymond James | Outperform |
2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity Partners with Genomics England to Screen 100,000 Newborns for Rare Conditions | RVTY Stock News - StockTitan
Revvity CEO to Present Strategic Update at Evercore ISI HealthCONx Conference | PKI Stock News - StockTitan
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells - BioSpace
Revvity CEO to Present Strategic Update at Evercore ISI HealthCONx Conference | RVTY Stock News - StockTitan
Revvity updates organizational structure - Nasdaq
Revvity Announces Major Restructuring, Sets 2024 Investor Day for Strategic Update | RVTY Stock News - StockTitan
Sumitomo Mitsui Trust Group Inc. Purchases 9,473 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Impax Asset Management Group plc Sells 10,233 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Select Equity Group, L.P. Reduces Stake in Revvity Inc - GuruFocus.com
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
T. Rowe Price Investment Management, Inc. Reduces Stake in Revvi - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Shares in R - GuruFocus.com
Sivik Global Healthcare LLC Purchases New Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Bretton Capital Management LLC Invests $1.41 Million in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative - Simply Wall St
Capital Research Global Investors Bolsters Position in Revvity I - GuruFocus.com
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
These Analysts Revise Their Forecasts On Revvity Following Q3 Results - MSN
FY2024 EPS Estimates for Revvity Boosted by Leerink Partnrs - MarketBeat
Revvity stock price target lifted, outperform rating on strong results By Investing.com - Investing.com Canada
Revvity Inc. stock rises Tuesday, still underperforms market - MarketWatch
TD Cowen Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Raymond James Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
TD Cowen increases Revvity stock price target, keeps buy on stable signs - Investing.com Canada
Revvity Announces Financial Results for the Third Quarter of 2024 - BioSpace
Revvity, Inc. (NYSE:RVTY) Q3 2024 Earnings Call Transcript - Insider Monkey
Revvity stock price target lifted, outperform rating on strong results - Investing.com India
Revvity beats Q3 expectations, raises full-year EPS outlook - Investing.com India
Revvity Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges - GuruFocus.com
KeyBanc maintains $132 target on Revvity amid EPS guidance raise By Investing.com - Investing.com Canada
Revvity Inc price target raised to $134 by Evercore ISI - Investing.com Canada
Q3 2024 Revvity Inc Earnings Call - Mujer es Más
Revvity Reports Strong Q3 Growth and New Share Buyback - TipRanks
Revvity Adjusts Revenue Forecast But Lifts Profit Expectations - Finimize
Earnings call: Revitty reports solid Q3 with $684 million in revenue - Investing.com
Revvity (NYSE:RVTY) Hits New 52-Week HighWhat's Next? - MarketBeat
KeyBanc maintains $132 target on Revvity amid EPS guidance raise - Investing.com
RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised - MSN
Revvity Inc (RVTY) Shares Up 5.6% on Nov 4 - GuruFocus.com
Developing image-based T-cell assays for monitoring apoptosis and CAR expression - News-Medical.Net
Revvity climbs after raising 2024 profit forecast - XM
Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings - Yahoo Finance
Q3 2024 Revvity Inc Earnings Call Transcript - GuruFocus.com
Revvity cuts 2024 revenue forecast amid biotech spending slowdown - Reuters
Revvity Inc (RVTY) Q3 2024 Earnings: Revenue Hits $684M, GAAP EPS Soars to $0.77, Surpassing Estimates - GuruFocus.com
Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Revvity: Q3 Earnings Snapshot - San Antonio Express-News
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):